Out of Sight but Not Out of Mind: Caring for Patients Receiving OPAT During the SARS-CoV-2 Pandemic
- PMID: 32782914
- PMCID: PMC7408177
- DOI: 10.1093/ofid/ofaa309
Out of Sight but Not Out of Mind: Caring for Patients Receiving OPAT During the SARS-CoV-2 Pandemic
Abstract
In an effort to "flatten the curve" of SARS-CoV-2, society is urged to practice social distancing. However, the management of other disease states may require some patients to undergo outpatient parenteral antimicrobial therapy (OPAT). Practical considerations for OPAT management during an infectious pandemic are reviewed. These include shortening durations of therapy, utilizing the oral route, avoiding medications requiring therapeutic drug monitoring, selecting antimicrobials with long durations, decreasing frequency of laboratory blood draws, and performing tele-health visits.
Keywords: COVID-19; OPAT; SARS-2-CoV.
© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
References
-
- Norris AH, Shrestha NK, Allison GM, et al. . 2018 Infectious Diseases Society of America clinical practice guideline for the management of outpatient parenteral antimicrobial therapy. Clin Infect Dis 2019; 68:e1–35. - PubMed
-
- Seaton RA, Ritchie ND, Robb F, Stewart L, White B, Vallance C. From “OPAT” to “COpAT”: implications of the OVIVA study for ambulatory management of bone and joint infection. J Antimicrob Chemother 2019; 74:2119–21. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
